Market Closed

INKT
MiNK Therapeutics
$ 9.34
-1.99%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

MiNK Therapeutics News

Latest MiNK Therapeutics Stock News & INKT Headlines

MiNK Therapeutics, Inc. (INKT) Q3 2026 Earnings Call Transcript
4 days ago | seekingalpha.com
MiNK Therapeutics, Inc. (INKT) Reports Q3 Loss, Beats Revenue Estimates
4 days ago | zacks.com
What MiNK Therapeutics (INKT) Said on Its Q3 Earnings Call
4 days ago | marketbeat.com
MiNK Therapeutics Selected for ARPA-H-Funded Initiative to Advance Room-Temperature Cell Therapy
2 months ago | globenewswire.com
MiNK Therapeutics, Inc. (INKT) Q2 2026 Earnings Call Transcript
3 months ago | seekingalpha.com
MiNK Therapeutics Q2 Earnings Call Highlights
3 months ago | marketbeat.com
MiNK Therapeutics Reports Second Quarter 2026 Financial Results and Reports Observations from Randomized Phase 2 Trial of agenT-797 in Acute Lung Injury
3 months ago | globenewswire.com
MiNK Therapeutics to Report Second Quarter 2026 Financial Results, Provide Clinical Updates on agenT-797 in Lung Injury, and Highlight Important Business Updates
3 months ago | globenewswire.com
Here's Why You Should Add INKT Stock to Your Portfolio Now
4 months ago | zacks.com
MiNK Therapeutics Announces its Virtual 2026 Annual Shareholders Meeting
5 months ago | globenewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

INKT
MiNK Therapeutics
$ 9.34
-1.99%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago